Related MeSH Hierarchy (4)
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Gastrointestinal Neoplasms » Intestinal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Gastrointestinal Neoplasms » Intestinal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastrointestinal Neoplasms » Intestinal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Intestinal Neoplasms
Description
Tumors or cancer of the INTESTINES. MeSH
Hierarchy View
Subtype Terms (6)
Colorectal Neoplasms
1304 drugs (362 approved, 942 experimental)
Duodenal Neoplasms
11 approved drugs
Phase 4 Indicated Drugs (79)
Phase 3 Indicated Drugs (47)
Phase 2 Indicated Drugs (113)
allogeneic hematopoietic stem cells (Hemacord)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin)
autologous cytokine induced killer cells
autologous hematopoietic stem cells
autologous immunoglobulin idiotype-klh conjugate vaccine
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (18)
Organization Involved with Phase 2 Indications (48)
Case Western Reserve University
Children's Cancer and Leukaemia Group
Chinese Academy of Medical Sciences
European Organisation for Research and Treatment of Cancer
Hellenic Cooperative Oncology Group
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.